CMS Open Payments · Program Year 2024
Ossur Americas, Inc.
Ossur Americas, Inc. reported $259,215.08 across General Payments, Research, and Ownership to 1,080 physicians and teaching hospitals across 1,080 transactions.
- $259.2K Above-median payer
- All-tracks total
- 1,080 Above-median volume
- Transactions
- 1,080 Above-median reach
- Recipients
- #925
- of 1,925 companies
Ossur Americas, Inc. reported $259,215.08 across all CMS Open Payments tracks (General + Research + Ownership) to 1,080 physicians and teaching hospitals in Program Year 2024 - ranking #925 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $259,215.08, averaging $240.01 per recipient.
Ossur Americas, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
12/100
Transaction volume
F
18/100
Physician reach
F
18/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ossur-americas-inc Ossur Americas, Inc.
$259.2K · #925/1,925 · 0.0% industry · PY2024
- TOT $259.2K
- RANK #925
- SHARE 0.0%
- TXN 1,080
- RCP 1,080
- CAT 2
- GEN $259.2K
- TOP1 23.1%
- PY 2024
Volume peers
Nearest volume peer: ClearFlow Inc. ($259.3K)
Ossur Americas, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Ossur Americas, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Ossur Americas, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Grant" leads the 2-category general-payment breakdown below at $219.8K (84.8% of General Payments, 19 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Grant" leads Ossur Americas, Inc.'s 2-category general-payment breakdown at $219.8K, 84.8% of the reported total.
How Ossur Americas, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Grant | $219.8K | 19 | 84.8% |
| Food and Beverage | $39.4K | 1,061 | 15.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $209,833.00 (80.9%) of $259,215.08 in this company's General Payments records across 739 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ossur Americas, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Hospital For Special Surgery
$60,000.00 across 5 reported transactions
- 2
Rush University Medical Center
$50,000.00 across 4 reported transactions
- 3
Emory University Hospital
$49,000.00 across 4 reported transactions
- 4
Morristown Medical Center
$28,333.00 across 2 reported transactions
- 5
Ochsner Clinic Foundation
$22,500.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Ossur Americas, Inc.'s spend rank (#925 of 1,925, top 48% by spend) and concentration rank (#872 of 1,838, top 47% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Werfen USA LLC : $53.8K total payments, HHI 1491
- Helena Laboratories Corporation : $3.7K total payments, HHI 1489
- Ascend Therapeutics US, LLC : $74.6K total payments, HHI 1486
- curasan, Inc. : $621.57 total payments, HHI 1486
- Calyxo, Inc. : $311.2K total payments, HHI 1484
- Wenzel Spine, Inc. : $6.5K total payments, HHI 1484
- Ossur Americas, Inc. (this company) : $259.2K total payments, HHI 1476
- Nexus CMF, LLC : $69.0K total payments, HHI 1476
- Vertex Pharmaceuticals Incorporated : $6.9M total payments, HHI 1475
- Theragen, Inc. : $28.8K total payments, HHI 1475
- Ferring Pharmaceuticals AS : $71.5K total payments, HHI 1474
- Dunamis Medical, LLC : $6.0K total payments, HHI 1473
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Ossur Americas, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ossur Americas, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Ossur Americas, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Urgo Medical North America, LLC
Surgical Information Sciences, Inc.
IQ Med LLC
Ascensia Diabetes Care Us Inc.
ETS Wound Care LLC
Put this to use
Ossur Americas, Inc. ranks #925 of 1,925 by all-tracks total payments, led by "Grant".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Grant" spend across every manufacturer, not just Ossur Americas, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.